The pharmacologic and psychological treatment of obsessive-compulsive disorder

Canadian Journal of Psychiatry

Volumn 51, Issue 7, 2006, Pages 405-406

  Pinard, Gilbert ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; NEUROLEPTIC AGENT; SERTRALINE;

ANXIETY DISORDER; BEHAVIOR THERAPY; BRAIN DEPTH STIMULATION; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; EDITORIAL; GROUP THERAPY; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PATIENT COMPLIANCE; PSYCHOTHERAPY; TREATMENT OUTCOME; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 33745987617     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370605100701     Document Type: Editorial

References (12)

1. Rufer M, Hand I, Alsleben H, Braatz A, Ortmann J, Katenkamp B, and others. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo. Eur Arch Psychiatry Clin Neurosci 2005;255:121-8.
2. Foa EB, Liebowitz MR, Kozak M, Davies S, Campeas R, Franklin ME, and others. Randomized, placebo controlled trial, of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005;162:151-61.
3. Pediatric OCD Treatment study (POTS). Cognitive-behavior therapy, sertraline and their combination for children and adolescents with obsessive-compulsive disorder. Randomized controlled trial. JAMA 2004;16:1969-76.
4. Kampman M, Keijsers GPJ, Hoogduin CAL, Verbraak MJPM. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. Acta Psychiatr Scand 2002;106:314-9.
5. Franklin M, Simpson HB. Combining pharmacotherapy and exposure plus ritual prevention for obsessive compulsive disorder: research findings and clinical applications. Journal of Cognitive Psychotherapy: An International Quarterly 2005;1:317-30.
6. Salkovskis P. Obsessional-compulsive problems: a cognitive-behavioural analysis. Behav Res Ther 1985;23:571-83.
7. Sookman D, Pinard G, Beck AT.Vulnerability schemas in obsessive-compulsive disorder. Journal of Cognitive Psychotherapy: An International Quarterly 2001;15:109-30.
8. Shafran R, Thordarson DS, Rachman S. Thought-action fusion in obsessive-compulsive disorder. J Anxiety Disord 1996;10:379-91.
9. Sookman D, Pinard G. Integrative cognitive therapy for obsessive-compulsive disorders: a focus on multiple schemas. Cogn Behav Pract 1999;6:351-62.
10. Radomsky A, Taylor S. Subtyping OCD: prospects and problems. Behav Ther 2005;36:371-81.
11. Hollander E, Benzaquen S. Is there a distinct OCD spectrum? CNS Spectrums 1996;1:17-25.
12. Abelson JL, Curtis GC, Sagher O, Albucher RC, Harrigan M, Taylor SF, and others. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry 2005;57:510-6.